CHRS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Coherus Oncology Inc (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.0164, suggesting CHRS is Strong Buy.

Coherus Oncology Inc (CHRS) 20-Day simple moving average is 1.817, while Coherus Oncology Inc (CHRS) share price is $1.95, making it Buy.

Coherus Oncology Inc (CHRS) 60-Day simple moving average is 1.73, while Coherus Oncology Inc (CHRS) share price is $1.95, making it Buy.

Technical Analysis for CHRS

Technical Sentiment Analysis for Coherus Oncology Inc (CHRS) As of 2026-05-11, Coherus Oncology Inc (CHRS) is exhibiting a Strong Buy technical sentiment. Our proprietary analysis, which aggregates 14 technical signals, shows that 13 indicators are flashing buy, while 1 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for CHRS stands at 61.281, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.0164, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 35.486 and the Commodity Channel Index (CCI) at 168.815 further confirm a 0.11 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, CHRS is trading above its 60-day moving average of $1.73 and above its 200-day long-term moving average of $1.539. Key price levels to watch include the immediate resistance at $2.024 and strong support at $1.62. A break above $2.024 could signal a bull continuation, while falling below $1.62 may test the next Fibonacci floor at $1.459.

Coherus Oncology Inc (CHRS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	1.216	1.459	1.62	1.863	2.024	2.266	2.428
Fibonacci	1.459	1.613	1.708	1.863	2.017	2.112	2.266

Coherus Oncology Inc (CHRS) Technical Indicators

2026-05-11

Name	Value
RSI_14	61.281
STOCHk_14_3_3	35.486
STOCHd_14_3_3	27.084
CCI_20	168.815
AO_5_34	0.0502
MOM_10	0.11
MACD_12_26_9	0.0164

Coherus Oncology Inc (CHRS) Relative Strength Index (RSI) is 61.281, creating a Neutral signal.

Coherus Oncology Inc (CHRS) Stochastic Oscillator is 35.486, creating a Neutral signal.

Coherus Oncology Inc (CHRS) Stochastic RSI is 27.084, creating a Neutral signal.

Coherus Oncology Inc (CHRS) Commodity Channel Index (CCI) is 168.815, creating a Sell signal.

Coherus Oncology Inc (CHRS) Awesome Oscillator is 0.0502, creating a Buy signal.

Coherus Oncology Inc (CHRS) Momentum is 0.11, creating a Buy signal.

Coherus Oncology Inc (CHRS) MACD is 0.0164, creating a Buy signal.

Coherus Oncology Inc (CHRS) Moving Average

2026-05-11

Period	Simple	Signal
MA_5	1.8	Buy
MA_10	1.782	Buy
MA_20	1.817	Buy
MA_60	1.73	Buy
MA_200	1.539	Buy
MA_250	1.393	Buy

Coherus Oncology Inc (CHRS) 5-Day simple moving average is 1.8, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

Coherus Oncology Inc (CHRS) 10-Day simple moving average is 1.782, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

Coherus Oncology Inc (CHRS) 20-Day simple moving average is 1.817, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

Coherus Oncology Inc (CHRS) 60-Day simple moving average is 1.73, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

Coherus Oncology Inc (CHRS) 200-Day simple moving average is 1.539, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

Coherus Oncology Inc (CHRS) 250-Day simple moving average is 1.393, while Coherus Oncology Inc (CHRS) share price is $1.95, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for CHRS?

The overall technical consensus for Coherus Oncology Inc (CHRS) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 7 buy signals and 1 sell signals.

What are the key support and resistance levels for Coherus Oncology Inc (CHRS) today?

Based on pivot point calculations, Coherus Oncology Inc (CHRS) has an immediate support level at 1.62 and a major resistance level at 2.024. Traders also monitor the pivot point at 1.863 to determine the intraday trend direction.

Is Coherus Oncology Inc (CHRS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Coherus Oncology Inc (CHRS) is currently 61.281. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Coherus Oncology Inc (CHRS)?

Coherus Oncology Inc (CHRS) Moving Averages Convergence Divergence (MACD) indicator is 0.0164, suggesting CHRS is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for Coherus Oncology Inc.

How is Coherus Oncology Inc (CHRS) performing relative to its 200-day moving average?

Coherus Oncology Inc (CHRS) is currently trading at $1.95, which is above its 200-day simple moving average of 1.539. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.